Thujone Herbal Supplement: The GABA Molecule That Made Absinthe Illegal

The Oasis Health Journal · Submitted August 18, 2026 · 10:00 AM EDT

By Marlo Quist · Edited by Priya Raman, C.N.C.

Thujone is the molecule that made absinthe illegal for ninety years.

The FDA banned it in 1912 because they believed it caused hallucinations, convulsions, and madness. The thujone herbal supplement you can buy today comes from the same plant family, marketed for mood and relaxation. What changed between the ban and the capsule was not the molecule. What changed was that someone finally tested it in actual humans and found it unimpressive.

That is how science works when you skip the middle part.

Thujone is a terpenoid compound found in wormwood, white sage, and alpine sage. A 2026 review in Plants catalogued plant-derived compounds that interact with neurotransmitter systems and listed thujone as a GABA receptor modulator based on binding assays. The same review noted that most preclinical evidence for herbal mood support compounds stops at the test tube, where molecules look capable of all kinds of things they never actually do in a living person.

The test tube is where thujone has a resume.

People are where it gets a performance review.

What The Thujone Herbal Supplement Actually Contains

Alpine sage extract is sold as a natural herbal mood support product, often standardized to essential oil content. The oil contains thujone, but the label does not say how much. 'Standardized to essential oil' could mean five percent thujone or it could mean trace amounts and a nice smell.

That is not standardization. That is a cloud with a percentage sign on it.

A 2026 integrative review of lemon balm noted that bioactivity in herbal preparations is 'strongly preparation-dependent,' which is research language for 'what you bought may not be what was studied.' The review compared polyphenol-rich extracts to volatile oil fractions and found that clinical trial results varied wildly depending on which part of the plant was used and how it was processed.

Thujone exists in sage. What does not exist is clarity about the dose.

The Absinth Botanical Compound With GABA Activity In Dishes, Not People

The 2026 Plants review on cognitive health compounds included terpenoids as a class and noted GABA receptor activity for thujone in binding assays. It did not cite a single human trial on thujone specifically. It cited trials on ginkgo diterpenes, saffron, curcumin, and rosmarinic acid, all of which had controlled studies with actual participants and measurable outcomes.

Thujone had receptor data and a reputation.

The original absinthe panic centered on the idea that thujone caused excitation and seizures by interfering with GABA, the brain's main inhibitory neurotransmitter. The problem is that nobody measured whether the thujone content in actual absinthe could reach the brain at levels that would do anything a neuron would notice. They measured the molecule's behavior in isolation and declared the drink dangerous.

At the doses people actually consumed, the alcohol would affect you long before the thujone did.

The thujone would just be there, like a cousin at Thanksgiving.

What People In The Alps Actually Used It For

A 2023 ethnobotanical survey in the Susa Valley of northwest Italy recorded traditional uses of local medicinal plants over a fifty-year period. The study documented Artemisia genipi, alpine wormwood, as a digestive bitter used to make liqueur. Nobody mentioned mood. They mentioned digestion and homemade alcohol, which is the same thing people mention about every bitter herb when you ask them what it is for.

The study noted a significant decline in traditional plant knowledge over the past half-century due to depopulation and cultural change. Younger residents could not name the plants their grandparents used.

The plants are still there. The knowledge left with the people.

What survived is the liqueur.

A 2025 review of medicinal plants for gut health mentioned fennel, chamomile, ginger, and dandelion for gastrointestinal support but did not list wormwood or thujone-containing sage species. The compounds that made the gut health list were those with prebiotic, anti-inflammatory, or antimicrobial effects demonstrated in controlled conditions.

Thujone did not make the list because thujone studies measure binding, not digestion.

The Supplement You Can Buy vs. The Studies That Do Not Exist

If you are searching where to buy thujone herbal extract, it is available from multiple supplement retailers, usually as sage extract capsules or essential oil blends. What is not available is a single published human trial measuring thujone's effect on mood, anxiety, sleep, or cognition at supplement doses.

Not one.

The 2026 review on lemon balm noted that the most consistent clinical signals for herbal anxiolytics came from trials using standardized preparations with known active compound concentrations and validated outcome measures. Lemon balm had those trials. Chamomile had those trials.

Thujone does not.

A 2025 review of Echium species noted that while the genus contains bioactive terpenoids, alkaloids, and polyphenols, 'the bioactivities observed substantiate the necessity for preclinical and clinical investigations to thoroughly elucidate and validate the therapeutic potential.' That sentence is what you write when the plant has compounds but no human data.

Thujone has compounds.

The GABA receptor activity happens in assays under controlled laboratory conditions. Whether that activity occurs in the human brain at doses achievable through oral supplementation is a question nobody has answered in a published trial. The dose that fits in a capsule may do nothing a neurotransmitter system would notice, or it may do something nobody has bothered to measure in a way that would survive peer review.

The molecule made absinthe illegal. It did not make absinthe interesting.

The alcohol did that. Thujone just had good marketing, which in 1912 meant a moral panic and in 2026 means a search term.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Unlocking the Power of Plant-Derived Natural Products: Therapeutic Benefits for Cognitive Health and Neuropsychiatric Symptoms in Dementia-Related Diseases, Plants (Basel, Switzerland) (2026).
2. <i>Melissa officinalis</i> L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies, Plants (Basel, Switzerland) (2026).
3. Medicinal Plants for a Healthy Gut Microbiome: Scientific Insights into Modern Herbal Applications, International journal of molecular sciences (2025).
4. Genus <i>Echium</i> L.: Phytochemical Characterization and Bioactivity Evaluation for Drug Discovery, Plants (Basel, Switzerland) (2025).
5. Traditional Knowledge Evolution over Half of a Century: Local Herbal Resources and Their Changes in the Upper Susa Valley of Northwest Italy, Plants (Basel, Switzerland) (2023).